Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer

Published:2013-10 Issue:10 Volume:8 Page:1308-1316
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Choy Hak,Schwartzberg Lee S.,Dakhil Shaker R.,Garon Edward B.,Gerber David E.,Choksi Janak K.,Govindan Ramaswamy,Peng Guangbin,Koustenis Andrew,Treat Joseph,Obasaju Coleman

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy;Lee;Clin Lung Cancer,2006

2. The role of chemotherapy and radiation in the treatment of locally advanced non-small cell lung cancer (NSCLC);Wagner;Curr Drug Targets,2010

3. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial;Albain;Lancet,2009

4. Molecular, biochemical, and cellular pharmacology of pemetrexed;Goldman;Semin Oncol,2002

5. Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro;Bischof;Int J Radiat Oncol Biol Phys,2002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers;Current Oncology;2024-03-20

2. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

3. Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review;Frontiers in Pharmacology;2023-06-13

4. Locally Advanced Lung Cancer;Hematology/Oncology Clinics of North America;2023-06

5. Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?;Current Oncology;2022-10-31